Back

Mineral oil and icosapent ethyl may jointly explain the between arm difference of cardiovascular risk in REDUCE-IT

European Heart Journal

3 November 2021
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Takahito Doi
Takahito Doi

Author

Anne Langsted
Anne Langsted

Author

Børge G Nordestgaard
Børge G Nordestgaard

Author

Copenhagen University Hospital Copenhagen , Denmark

You may be interested in
thumbnail
Congress Presentation
REDUCE-IT: outcomes by baseline statin type
28 August 2020
thumbnail
Congress Presentation
A continuum of multifactorial benefits of icosapent ethyl.
26 August 2022
thumbnail
Congress Presentation
Cardiovascular risk reduction & hypertriglyceridemia: integrating the evidence
29 August 2025
thumbnail
Congress Presentation
Icosapent ethyl reduces cardiovascular risk across apolipoprotein b and fasting triglyceride rich lipoprotein levels
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources